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Clinicians Advised to Halt Use of Propofol from Tainted Lots
The Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA) 
have been investigating recent cases of febrile reactions among patients undergoing endoscopy in the 
United States.
This investigation has revealed that all of the case-patients received the anesthetic propofol from 100 ml 
vials manufactured byTeva Pharmaceuticals.
Testing done by the FDA has found that two lots of this product that were in use in facilities reporting 
febrile reactions were positive for elevated levels of endotoxin.
The lots are 31305429B and 31305430B.
Teva Pharmaceuticals is initiating a voluntary recall for these lots, and clinicians are advised to 
immediately stop using these lots of Teva Pharmaceuticals propofol.
CDC, FDA and Teva Pharmaceuticals are continuing to investigate this issue.
To date, all case-patients have recovered.
As additional information about the recall becomes available, an updated Health Alert Notice will be 
provided.
The Centers for Disease Control and Prevention (CDC) protects people's health and safety by 
preventing and controlling diseases and injuries; enhances health decisions by providing credible 
information on critical health issues; and promotes healthy living through strong partnerships with
local, national and international organizations.
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